More than 4 million people in the United States are infected with hepatitis C and about 1.5 million people nationwide are infected with chronic hepatitis B. Hepatitis B and C are silent diseases, meaning they are difficult to detect because patients are often asymptomatic. Although hepatitis is curable, untreated hepatitis is a significant risk factor for liver cancer.
Screening and maintaining healthy lifestyle practices are key for prevention of hepatitis B and C. Rajender Reddy, MD, director of hepatology and medical director of the liver transplantation program at the Hospital of the University of Pennsylvania says: "Penn Medicine is at the cutting edge of research and development of new forms of therapy for treatment of hepatitis B and C."
Penn Gastroenterology is currently involved in 15 research studies and recently added four new hepatologists to the staff.
Penn Gastroenterology
Hepatitis B
Hepatitis C
.
kim kardashian gives birth to baby
